secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOLIFE SOLUTIONS INC (BLFS)
CIK:        0000834365
Form:       8-K
Filed at:   2026-09-09T21:21:52+00:00
Accession:  0001628280-26-061174
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

BioLife HSR waiting period expires for Repligen acquisition; vote set for Oct 5
-------------------------------------------------------------------------------

- HSR waiting period expired Sept 3, 2026, clearing antitrust condition for Repligen merger.
- Deal consideration: $11.25 cash + 0.1442 Repligen shares per BioLife share.
- Special stockholder meeting to vote on merger scheduled Oct 5, 2026 at 9:00 a.m. ET.
- Merger still subject to other closing conditions, including BioLife stockholder approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/834365/000162828026061174/0001628280-26-061174-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/834365/000162828026061174/blfs-20260903.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-061174

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer